Nystagmus and oscillopsia

European Journal of Neurology

Volumn 19, Issue 1, 2012, Pages 6-14

  Straube, A ^a   Bronstein, A ^b   Straumann, D ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Neuro ophthalmology; Neurological disorder; Nystagmus; Ocular movements; Vestibular disorder

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ALCOHOL; BACLOFEN; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CANNABIS; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; IMMUNOGLOBULIN; ISONIAZID; LIDOCAINE; MEMANTINE; MEXILETINE; NITRAZEPAM; PHENOTHIAZINE; PHENYTOIN; PHYSOSTIGMINE; PLACEBO; PREDNISOLONE; PROPRANOLOL; SCOPOLAMINE; THIAMINE; TRIDIHEXETHYL CHLORIDE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

ACQUIRED PENDULAR NYSTAGMUS; ARNOLD CHIARI MALFORMATION; ARTICLE; BRAIN DEGENERATION; BROWN SYNDROME; CONGENITAL NYSTAGMUS; DECOMPRESSION SURGERY; ENCEPHALITIS; EYE FIXATION; EYE MOVEMENT DISORDER; GAZE; HEAD MOVEMENT; HUMAN; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; NYSTAGMUS; OCULAR FLUTTER; OPSOCLONUS; OSCILLOPSIA; PATHOPHYSIOLOGY; PERIODIC ALTERNATING NYSTAGMUS; PRIORITY JOURNAL; SEESAW NYSTAGMUS; TUMOR; UPBEAT NYSTAGMUS; VESTIBULAR DISORDER;

HUMANS; NYSTAGMUS, PATHOLOGIC; OCULAR MOTILITY DISORDERS;

EID: 84155167065     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03503.x     Document Type: Article

References (101)

1. Grüsser OJ. Some recent studies on the quantitative analysis of efference copy mechanisms in visual perception. Acta Psychol (Amst) 1986; 63: 49-62.
2. Hilgers R-D. Qualitätsbeurteilung von Studien zur klinischen Effektivität. In: Lauterbach KW, Schrappe M eds. Gesundheitsökonomie, Qualitätsmanagement Und Evidence-Based Medicine. Stuttgart: Schattauer, 2001: 89-95.
3. Straube A, Leigh RJ, Bronstein A, et al. EFNS task force - therapy of nystagmus and oscillopsia. Eur J Neurol 2004; 11: 83-89.
4. Rinne T, Bronstein AM, Rudge P, Gresty MA, Luxon LM. Bilateral loss of vestibular function: clinical findings in 53 patients. J Neurol 1998; 245: 314-321.
5. Marti S, Palla A, Straumann D. Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus. Ann Neurol 2002; 52: 712-721.
6. Bronstein AM, Miller DH, Rudge P, Kendall BE. Down beating nystagmus: magnetic resonance imaging and neuro-otological findings. J Neurol Sci 1987; 81: 173-184.
7. Büchele W, Brandt T, Degner D. Ataxia and oscillopsia in downbeat-nystagmus vertigo syndrome. Adv Otorhinolaryngol 1983; 30: 291-297.
8. Baloh RW, Spooner JW. Downbeat nystagmus. A type of central vestibular nystagmus. Neurology 1981; 31: 304-310.
9. Zee DS, Friendlich AR, Robinson DA. The mechanism of downbeat nystagmus. Arch Neurol 1974; 30: 227-237.
10. Glasauer S, Hoshi M, Kempermann U, Eggert T, Büttner U. Three-dimensional eye position and slow phase velocity in humans with downbeat nystagmus. J Neurophysiol 2003; 89: 338-354.
11. Marti S, Straumann D, Büttner U, Glasauer S. A model-based theory on the origin of downbeat nystagmus. Exp Brain Res 2008; 188: 613-631.
12. Halmagyi MG, Rudge P, Gresty MA, Sanders MD. Down-beating nystagmus. A review of 62 cases. Arch Neurol 1983; 40: 777-784.
13. Wagner JN, Glaser M, Brandt T, Strupp M. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 2008; 79: 672-677.
14. Wagner J, Lehnen N, Glasauer S, Strupp M, Brandt T. Prognosis of idiopathic downbeat nystagmus. Ann NY Acad Sci 2009; 1164: 479-481.
15. Strupp M, Schüler O. Improvement of downbeat nystagmus and postural imbalance by 3, 4-diaminopyridine, a prospective, placebo-controlled study. J Vestib Res 2002; 11: 226.
16. Currie J, Matsuo V. The use of clonazepam in the treatment of nystagmus induced oscillopsia. Ophthalmology 1986; 93: 924-932.
17. Dieterich M, Straube A, Brandt T, Paulus W, Büttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nsytagmus. J Neurol Neurosurg Psychiatry 1991; 54: 627-632.
18. Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997; 41: 818-825.
19. Barton JJS, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 1994; 35: 319-325.
20. Pedersen RA, Troost BT, Abel LA, Zorub D. Intermittent down beat nystagmus and oscillopsia reversed by suboccipital craniectomy. Neurology 1980; 30: 1232-1242.
21. Spooner JW, Baloh RW. ArnoldChiari malformation. Improvement in eye movements after surgical treatment. Brain 1981; 104: 51-60.
22. Liebenberg WA, Georges H, Demetriades AK, Hardwidge C. Does posterior fossa decompression improve oculomotor and vestibulo-ocular manifestations in Chiari 1 malformation? Acta Neurochir (Wien) 2005; 147: 1239-1240.
23. Strupp M, Schüler O, Krafczyk S, et al. Treatment of down-beat nystagmus with 3, 4-diaminopyridine a prospective, placebo-controlled, double-blind study. Neurology 2003; 61: 165-170.
24. Kalla R, Glasauer S, Schautzer F, et al. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology 2004; 62: 1228-1229.
25. Sprenger A, Rambold H, Sander T, et al. Treatment of the gravity dependence of downbeat nystagmus with 3, 4-diaminopyridine. Neurology 2006; 67: 905-907.
26. Glasauer S, Kalla R, Büttner U, Strupp M, Brandt T. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 2005; 76: 451-453.
27. Halmagyi GM, Aw ST, Dehaene I, Curthoys IS, Todd MJ. Jerk-waveform see-saw nystagmus due to unilateral mesodiencephalic lesion. Brain 1994; 117: 775-788.
28. Endres M, Heide W, Kompf D. See-saw nystagmus. Clinical aspects, diagnosis, pathophysiology: observations in 2 patients. Nervenarzt 1996; 67: 484-489.
29. Rambold H, Helmchen C, Büttner U. Unilateral muscimol inactivations of the interstitial nucleus of Cajal in the alert rhesus monkey do not elicit seesaw nystagmus. Neurosci Lett 1999; 272: 75-78.
30. Stahl JS, Averbuch-Heller L, Leigh RJ. Acquired nystagmus. Arch Ophthalmol 2000; 118: 544-549.
31. Fisher A, Gresty M, Chambers B, Rudge P. Primary position upbeating nystagmus: a variety of central positional nystagmus. Brain 1983; 106: 949-964.
32. Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain 2005; 128(Pt 6): 1237-1246.
33. Frisèn L, Wikkelso C. Posttraumatic seesaw nystagmus abolished by ethanol ingestion. Neurology 1986; 36: 841-844.
34. Lepore FE. Ethanol-induced resolution of pathologic nystagmus. Neurology 1987; 37: 877.
35. Carlow TJ. Medical treatment of nystagmus and ocular motor disorders. Int Ophthalmol Clin 1986; 26: 251-264.
36. Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibuloocular reflex by the nodulus and uvula. Science 1985; 228: 199-202.
37. Furman JMR, Wall C, Pang D. Vestibular function in periodic alternating nystagmus. Brain 1990; 113: 1425-1439.
38. Halmagyi MG, Rudge P, Gresty MA. Treatment of periodic alternating nystagmus. Ann Neurol 1980; 8: 609-611.
39. Larmande P, Larmande A. Action du baclofene sur le nystagmus alternant periodique. Bull Mem Soc Fr Ophtalmol 1983; 94: 390-393.
40. Isago H, Tsuboya R, Kataura A. A case of periodic alternating nystagmus: with special reference to the efficacy of baclofen treatment. Auris Nasus Larynx 1985; 12: 15-21.
41. Nuti D, Ciacci G, Giannini F, Rossi A, Frederico A. Aperiodic alternating nystagmus: report of two cases and treatment by baclofen. Ital J Neurol Sci 1986; 7: 453-459.
42. Comer RM, Dawson EL, Lee JP. Baclofen for patients with congenital periodic alternating nystagmus. Strabismus 2006; 14: 205-209.
43. Nathanson M, Bergman PS, Bender MB. Visual disturbances as the result of nystagmus on direct forward gaze. Effect of amobarbital sodium. Arch Neurol Psychiatry 1953; 69: 427-435.
44. Kumar A, Thomas S, McLean R, et al. Treatment of acquired periodic alternating nystagmus with memantine: a case report. Clin Neuropharmacol 2009; 32: 109-110.
45. Cross SA, Smith JL, Norton EW. Periodic alternating nystagmus clearing after vitrectomy. J Clin Neuroophthalmol 1982; 2: 511.
46. Jay WM, Williams BB, De Chicchis A. Periodic alternating nystagmus clearing after cataract surgery. J Clin Neuroophthalmol 1985; 5: 149-152.
47. Al-Awami A, Flanders ME, Andermann F, Polomeno RC. Resolution of periodic alternating nystagmus after decompression for Chiari malformation. Can J Ophthalmol 2005; 40: 778-780.
48. Gresty M, Ell JJ, Findley LJ. Acquired pendular nystagmus: its characteristics, localising value and pathophysiology. J Neurol Neurosurg Psychiatry 1982; 45: 431-439.
49. Traccis S, Rosati G, Monaco MF, Aiello IN, Agnetti V. Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 1990; 40: 492-494.
50. Leigh RJ, Tomsak RL, Grant MP, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 1992; 32: 633-642.
51. Lopez LI, Bronstein AM, Gresty MA, Du Boulay EP, Rudge P. Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 1996; 119: 465-472.
52. Zee DS. Mechanisms of nystagmus. Am J Otolaryngol 1985; (Suppl.): 30-34.
53. Leigh RJ, Zee DS. The Neurology of Eye Movements, 3rd edn. New York: Oxford University Press, 1999.
54. Das VE, Oruganti P, Kramer PD, Leigh RJ. Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res 2000; 133: 189-197.
55. Herishanu Y, Louzoun Z. Trihexyphenidyl treatment of vertical pendular nystagmus. Neurology 1986; 36: 82-84.
56. Jabbari B, Rosenberg M, Scherokman B, Gunderson CH, McBurney JW, McClintock W. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 1987; 2: 93-98.
57. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ. The effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 1991; 41: 1737-1741.
58. Kim JI, Averbuch-Heller L, Leigh RJ. Evaluation of transdermal scopolamine as treatment for acquired nystagmus. J Neuro-Ophthalmol 2001; 21: 188-192.
59. Ell J, Gresty M, Chambers BR, Frindley L. Acquired pendular nystagmus: characteristics, pathophysiology and pharmacological modification. In: Roucoux A, Crommeilinck M (eds). Physiological and Pathological Aspects of Eye Movements. The Hague, Boston, and London: Dr W. Junk Publ, 1982: 89-98.
60. Starck M, Albrecht H, Pöllmann W, Straube A, Dieterich M. Drug therapy of acquired nystagmus in multiple sclerosis. J Neurol 1997; 244: 916.
61. Starck M, Albrecht H, Pöllmann W, Dieterich M, Straube A. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol 2010; 257: 322-327.
62. Leigh RJ, Averbuch-Heller L, Tomsak RL, Remler BF, Yaniglos SS, Dell'Osso LF. Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol 1994; 36: 129-141.
63. Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 2001; 71: 107-110.
64. Mossman SS, Bronstein AM, Rudge P, Gresty MA. Acquired pendular nystagmus suppressed by alcohol. Neuro-Ophthalmol 1993; 13: 99-106.
65. Schon F, Hart PE, Hodgson TL, et al. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 1999; 53: 2209-2210.
66. Dell'Osso LF. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 2000; 13: 2190-2191.
67. Ridley A, Kennard C, Scholtz CL, Büttner-Ennever JA, Summers B, Turnbull A. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 1987; 110: 1699-1709.
68. Helmchen C, Rambold H, Sprenger A, Erdmann C, Binkofski F; fMRI study. Cerebellar activation in opsoclonus: an fMRI study. Neurology 2003;61:412-415.
69. Ramat S, Leigh RJ, Zee DS, Optican LM. What clinical disorders tell us about the neural control of saccadic eye movements. Brain 2007; 130: 10-35.
70. Pless M, Ronthal M. Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology 1996; 46: 583-584.
71. Traccis S, Marras MA, Puliga MV, et al. Square-wave jerks and square-wave oscillations: treatment with valproic acid. Neuro-Ophthalmol 1997; 18: 51-58.
72. Serra A, Liao K, Martinez-Conde S, Optican LM, Leigh RJ. Suppression of saccadic intrusions in hereditary ataxia by memantine. Neurology 2008; 70: 810-812.
73. Leopold HC. Opsoklonus- und Myoklonie-Syndrom. Klinische und elektronystagmographische Befunde mit Verlaufsstudien. Fortschr Neurol Psychiatr 1985; 53: 42-54.
74. Nausieda PA, Tanner CM, Weiner WJ. Opsoclonic cerebellopathy. A paraneoplastic syndrome responsive to thiamine. Arch Neurol 1981; 38: 780-782.
75. Tusa RJ. Nystagmus: diagnostic and therapeutic strategies. Semin Ophthalmol 1999; 14: 65-73.
76. Hertle RW, Yang D. Clinical and electrophysiological effects of extraocular muscle surgery on patients with Infantile Nystagmus Syndrome (INS). Semin Ophthalmol 2006; 21: 103-110.
77. Yee RD, Baloh RW, Honrubia V. Effect of baclofen on congenital nystagmus. In: Lennerstrand G, Zee DS, Keller E (eds). Functional Basis of Ocular Motility. Oxford: Pergamon, 1982: 151-158.
78. Pradeep A, Thomas S, Roberts EO, Proudlock FA, Gottlob I. Reduction of congenital nystagmus in a patient after smoking cannabis. Strabismus 2008; 16: 29-32.
79. McLean R, Proudlock F, Thomas S, Degg C, Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol 2007; 61: 130-138.
80. Shery T, Proudlock FA, Sarvananthan N, McLean RJ, Gottlob I. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Br J Ophthalmol 2006; 90: 839-843.
81. Sarvananthan N, Proudlock FA, Choudhuri I, Dua H, Gottlob I. Pharmacologic treatment of congenital nystagmus. Arch Ophthalmol 2006; 124: 916-918.
82. Lee JP. Superior oblique myokymia: a possible etiologic factor. Arch Ophthalmol 1984; 102: 1178-1179.
83. Hashimoto M, Ohtsuka K, Hoyt WF. Vascular compression as a cause of superior oblique myokymia disclosed by thin-slice magnetic resonance imaging. Am J Ophthalmol 2001; 31: 676-677.
84. Yousry I, Dieterich M, Naidich TP, Schmid UD, Yousry TA. Superior oblique myokymia: magnetic resonance imaging support for the neurovascular compression hypothesis. Ann Neurol 2002; 51: 361-368.
85. Hoyt WF, Keane JR. Superior oblique myokymia: report and discussion of five cases of benign intermittent uniocular microtremor. Arch Ophthalmol 1962; 84: 461-467.
86. Leigh RJ, Tomsak RL, Seidman SH, Dell'Osso LF. Superior oblique myokymia. Quantitative characteristics of the eye movements in three patients. Arch Ophthalmol 1991; 109: 1710-1713.
87. Susac JO, Smith JL, Schatz NJ. Superior oblique myokymia. Arch Neurol 1973; 29: 432-434.
88. Rosenberg MI, Glaser JS. Superior oblique myokymia. Ann Neurol 1983; 13: 667-669.
89. Tomsak RL, Kosmorsky GA, Leigh RJ. Gabapentin attenuates superior oblique myokymia. Am J Ophthalmol 2002; 133: 721-723.
90. Tyler RD, Ruiz RS. Propranolol in the treatment of superior oblique myokymia. Arch Ophthalmol 1990; 108: 175-176.
91. Bibby K, Deane JS, Farnworth D, Cappin J. Superior oblique myokymia: a topical solution? Br J Ophthalmol 1994; 78: 882.
92. Palmer EA, Shults WT. Superior oblique myokymia: preliminary results of surgical treatment. J Pediatr Ophthalmol Strabismus 1984; 21: 91-101.
93. Brazis PW, Miller NR, Henderer JD, Lee AG. The natural history and results of treatment of superior oblique myokymia. Arch Ophthalmol 1994; 112: 1063-1067.
94. Samii M, Rosahl SK, Carvalho GA, Krzizok T. Microvascular decompression for superior oblique myokymia: first experience. J Neurosurg 1998; 89: 1020-1024.
95. Scharwey K, Krzizok T, Samii M, Rosahl SK, Kaufmann H. Remission of superior oblique myokymia after microvascular decompression. Ophthalmologica 2000; 214: 426-428.
96. Hüfner K, Barresi D, Glaser M, et al. Vestibular paroxysmia: diagnostic features and medical treatment. Neurology 2008; 71: 1006-1014.
97. Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 1994; 26: 798-799.
98. Straube A, Büttner U, Brandt T. Recurrent attacks with skew deviation, torsional nystagmus and contraction of the left frontalis muscle. Neurology 1994; 44: 177-178.
99. De Ridder D, Moller A, Verlooy J, Cornelissen M, De Ridder L. Is the root entry/exit zone important in micro-vascular compression syndromes? Neurosurgery 2002; 51: 427-433.
100. Brandt T. Vertigo. Its Multisensory Syndromes, 2nd edn. London: Springer-Verlag, 1999.
101. Jannetta PJ, Møller MD, Møller AR. Disabling positional vertigo. N Engl J Med 1984; 310: 1700-1705.